{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:14Z","timestamp":1793157914916,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01923-2","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T12:03:00Z","timestamp":1666958580000},"page":"727-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors"],"prefix":"10.1007","volume":"46","author":[{"given":"B.","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Beklen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Y.","family":"Arga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bayrakli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1330-9712","authenticated-orcid":false,"given":"B.","family":"Turanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"1923_CR1","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an international pituitary pathology club proposal. Endocr Relat Cancer 24:C5\u2013C8","journal-title":"Endocr Relat Cancer"},{"key":"1923_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea M-L, Vasiljevic A, Raverot G, Roncaroli F, Villa C (2020) How to classify pituitary neuroendocrine tumors (PitNET) s in 2020. Cancers (Basel) 12:514","journal-title":"Cancers (Basel)"},{"key":"1923_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy131","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"1923_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The Epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49:347\u2013355","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1923_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.endinu.2017.05.009","volume":"64","author":"M Mercado","year":"2017","unstructured":"Mercado M, Melgar V, Salame L, Cuenca D (2017) Clinically non-functioning pituitary adenomas: pathogenic, diagnostic and therapeutic aspects. Endocrinol diabetes y Nutr 64:384\u2013395","journal-title":"Endocrinol diabetes y Nutr"},{"key":"1923_CR6","volume-title":"WHO classification of tumours of endocrine organs","author":"RV Llyod","year":"2017","unstructured":"Llyod RV, Osamura RY, Kl\u00f6ppel GRJ (2017) WHO classification of tumours of endocrine organs. IARC, Lyon"},{"key":"1923_CR7","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s40618-020-01468-2","volume":"44","author":"ME Torregrosa-Quesada","year":"2021","unstructured":"Torregrosa-Quesada ME, Garc\u00eda-Mart\u00ednez A, S\u00e1nchez-Barbie A, Silva-Ortega S, C\u00e1mara R, Fajardo C, Pico A (2021) The silent variants of pituitary tumors: demographic, radiological and molecular characteristics. J Endocrinol Invest 44:1637\u20131648","journal-title":"J Endocrinol Invest"},{"key":"1923_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/756069","author":"G Vargas","year":"2015","unstructured":"Vargas G, Gonzalez B, Ramirez C, Ferreira A, Espinosa E, Mendoza V, Guinto G, Lopez-Felix B, Zepeda E, Mercado M (2015) Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2015\/756069","journal-title":"Int J Endocrinol"},{"key":"1923_CR9","doi-asserted-by":"crossref","unstructured":"Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S (2015) Management of clinically non-functioning pituitary adenoma. Annales d\u2019endocrinologie. Elsevier, pp 239\u2013247","DOI":"10.1016\/j.ando.2015.04.002"},{"key":"1923_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11102-017-0854-2","volume":"21","author":"DL Penn","year":"2018","unstructured":"Penn DL, Burke WT, Laws ER (2018) Management of non-functioning pituitary adenomas: surgery. Pituitary 21:145\u2013153","journal-title":"Pituitary"},{"key":"1923_CR11","doi-asserted-by":"publisher","first-page":"E533","DOI":"10.1227\/NEU.0000000000001389","volume":"79","author":"JW Lucas","year":"2016","unstructured":"Lucas JW, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Aghi MK, Zada G (2016) Congress of neurological surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery 79:E533\u2013E535","journal-title":"Neurosurgery"},{"key":"1923_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12020-015-0685-8","volume":"50","author":"Y Greenman","year":"2015","unstructured":"Greenman Y, Stern N (2015) Optimal management of non-functioning pituitary adenomas. Endocrine 50:51\u201355","journal-title":"Endocrine"},{"key":"1923_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11102-018-0865-7","volume":"21","author":"N Even-Zohar","year":"2018","unstructured":"Even-Zohar N, Greenman Y (2018) Management of NFAs: medical treatment. Pituitary 21:168\u2013175. https:\/\/doi.org\/10.1007\/s11102-018-0865-7","journal-title":"Pituitary"},{"key":"1923_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/EJE-10-0255","volume":"163","author":"S Brochier","year":"2010","unstructured":"Brochier S, Galland F, Kujas M, Parker F, Gaillard S, Raftopoulos C, Young J, Alexopoulou O, Maiter D, Chanson P (2010) Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol 163:193","journal-title":"Eur J Endocrinol"},{"key":"1923_CR15","doi-asserted-by":"publisher","first-page":"e3507","DOI":"10.1210\/clinem\/dgaa497","volume":"105","author":"MD Ilie","year":"2020","unstructured":"Ilie MD, Raverot G (2020) Treatment options for gonadotroph tumors: current state and perspectives. J Clin Endocrinol Metab 105:e3507\u2013e3518","journal-title":"J Clin Endocrinol Metab"},{"key":"1923_CR16","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/ijc.30613","volume":"140","author":"E Peverelli","year":"2017","unstructured":"Peverelli E, Giardino E, Treppiedi D, Meregalli M, Belicchi M, Vaira V, Corbetta S, Verdelli C, Verrua E, Serban AL (2017) Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor\/stem-like cells isolated from nonfunctioning pituitary tumors. Int J cancer 140:1870\u20131880","journal-title":"Int J cancer"},{"key":"1923_CR17","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1021\/acs.analchem.9b00914","volume":"91","author":"H Wang","year":"2019","unstructured":"Wang H, Chen K, Yang Z, Li W, Wang C, Zhang G, Zhu L, Liu P, Yang Y (2019) Diagnosis of invasive nonfunctional pituitary adenomas by serum extracellular vesicles. Anal Chem 91:9580\u20139589","journal-title":"Anal Chem"},{"key":"1923_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fendo.2019.00361","volume":"10","author":"B Aydin","year":"2019","unstructured":"Aydin B, Arga KY (2019) Co-expression network analysis elucidated a core module in association with prognosis of non-functioning non-invasive human pituitary adenoma. Front Endocrinol (Lausanne) 10:361","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1923_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8060148","author":"W Gossing","year":"2020","unstructured":"Gossing W, Frohme M, Radke L (2020) Biomarkers for liquid biopsies of pituitary neuroendocrine tumors. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines8060148","journal-title":"Biomedicines"},{"key":"1923_CR20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24183","author":"LC Hern\u00e1ndez-Ram\u00edrez","year":"2018","unstructured":"Hern\u00e1ndez-Ram\u00edrez LC, Morgan RML, Barry S, D\u2019Acquisto F, Prodromou C, Korbonits M (2018) Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.24183","journal-title":"Oncotarget"},{"key":"1923_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/BF03346759","volume":"36","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Kasuki L, D\u00e9nes J, Trivellin G, Korbonits M (2013) MicroRNAs: Suggested role in pituitary adenoma pathogenesis. J Endocrinol Invest 36:889\u2013895","journal-title":"J Endocrinol Invest"},{"key":"1923_CR22","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.3390\/ijms21197287","volume":"21","author":"O Beylerli","year":"2020","unstructured":"Beylerli O, Beeraka NM, Gareev I, Pavlov V, Yang G, Liang Y, Aliev G (2020) MiRNAs as noninvasive biomarkers and therapeutic agents of pituitary adenomas. Int J Mol Sci 21:7287","journal-title":"Int J Mol Sci"},{"key":"1923_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11102-010-0268-x","volume":"14","author":"H Butz","year":"2011","unstructured":"Butz H, Lik\u00f3 I, Czirj\u00e1k S, Igaz P, Korbonits M, R\u00e1cz K, Pat\u00f3cs A (2011) MicroRNA profile indicates downregulation of the TGF\u03b2 pathway in sporadic non-functioning pituitary adenomas. Pituitary 14:112\u2013124","journal-title":"Pituitary"},{"key":"1923_CR24","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","volume":"179","author":"P Cheunsuchon","year":"2011","unstructured":"Cheunsuchon P, Zhou Y, Zhang X, Lee H, Chen W, Nakayama Y, Rice KA, Hedley-Whyte ET, Swearingen B, Klibanski A (2011) Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 179:2120\u20132130","journal-title":"Am J Pathol"},{"key":"1923_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11102-014-0554-0","volume":"18","author":"Z Li","year":"2015","unstructured":"Li Z, Li C, Liu C, Yu S, Zhang Y (2015) Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. Pituitary 18:42\u201347. https:\/\/doi.org\/10.1007\/s11102-014-0554-0","journal-title":"Pituitary"},{"key":"1923_CR26","doi-asserted-by":"publisher","DOI":"10.1242\/bio.037127","author":"W Xing","year":"2019","unstructured":"Xing W, Qi Z, Huang C, Zhang N, Zhang W, Li Y, Qiu M, Fang Q, Hui G (2019) Genome-wide identification of lncRNAs and mRNAs differentially expressed in non-functioning pituitary adenoma and construction of an lncRNA-mRNA co-expression network. Biol Open. https:\/\/doi.org\/10.1242\/bio.037127","journal-title":"Biol Open"},{"key":"1923_CR27","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","volume":"76","author":"M Klutstein","year":"2016","unstructured":"Klutstein M, Nejman D, Greenfield R, Cedar H (2016) DNA methylation in cancer and aging. Cancer Res 76:3446\u20133450","journal-title":"Cancer Res"},{"key":"1923_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","volume":"41","author":"V Srirangam Nadhamuni","year":"2020","unstructured":"Srirangam Nadhamuni V, Korbonits M (2020) Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms. Endocr Rev 41:821\u2013846","journal-title":"Endocr Rev"},{"key":"1923_CR29","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.18632\/aging.102751","volume":"12","author":"S Cheng","year":"2020","unstructured":"Cheng S, Li C, Xie W, Miao Y, Guo J, Wang J, Zhang Y (2020) Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma. Aging (Albany NY) 12:2408","journal-title":"Aging (Albany NY)"},{"key":"1923_CR30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s40618-019-01178-4","volume":"43","author":"TM Vicchio","year":"2020","unstructured":"Vicchio TM, Aliqu\u00f2 F, Ruggeri RM, Ragonese M, Giuffrida G, Cotta OR, Ferra\u00f9 F (2020) MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior. J Endocrinol Investig 43:947\u2013958","journal-title":"J Endocrinol Investig"},{"key":"1923_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mce.2018.01.020","volume":"473","author":"P Kober","year":"2018","unstructured":"Kober P, Boresowicz J, Rusetska N, Maksymowicz M, Goryca K, Kunicki J, Bonicki W, Siedlecki JA, Bujko M (2018) DNA methylation profiling in nonfunctioning pituitary adenomas. Mol Cell Endocrinol 473:194\u2013204. https:\/\/doi.org\/10.1016\/j.mce.2018.01.020","journal-title":"Mol Cell Endocrinol"},{"key":"1923_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene Expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207\u2013210. https:\/\/doi.org\/10.1093\/nar\/30.1.207","journal-title":"Nucleic Acids Res"},{"key":"1923_CR33","volume-title":"LIMMA: linear models for microarray data","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, Ritchie M, Thorne N, Wettenhall J (2005) LIMMA: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor, Statistics for Biology and Health"},{"key":"1923_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:1\u201316","journal-title":"Genome Biol"},{"key":"1923_CR35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363\u20131369","journal-title":"Bioinformatics"},{"key":"1923_CR36","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, Teschendorff AE (2017) ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics 33:3982\u20133984","journal-title":"Bioinformatics"},{"key":"1923_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8935-8-6","volume":"8","author":"TJ Peters","year":"2015","unstructured":"Peters TJ, Buckley MJ, Statham AL, Pidsley R, Samaras K, Lord RV, Clark SJ, Molloy PL (2015) De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin 8:1\u201316","journal-title":"Epigenetics Chromatin"},{"key":"1923_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S (2013) A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29:189\u2013196. https:\/\/doi.org\/10.1093\/bioinformatics\/bts680","journal-title":"Bioinformatics"},{"key":"1923_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"Y Chen","year":"2013","unstructured":"Chen Y, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R (2013) Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:203\u2013209. https:\/\/doi.org\/10.4161\/epi.23470","journal-title":"Epigenetics"},{"key":"1923_CR40","doi-asserted-by":"publisher","first-page":"D793","DOI":"10.1093\/nar\/gks1055","volume":"41","author":"A Kamburov","year":"2013","unstructured":"Kamburov A, Stelzl U, Lehrach H, Herwig R (2013) The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res 41:D793\u2013D800. https:\/\/doi.org\/10.1093\/nar\/gks1055","journal-title":"Nucleic Acids Res"},{"key":"1923_CR41","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","journal-title":"Nat Commun"},{"key":"1923_CR42","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"M Kanehisa","year":"2008","unstructured":"Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36:D480\u2013D484. https:\/\/doi.org\/10.1093\/nar\/gkm882","journal-title":"Nucleic Acids Res"},{"key":"1923_CR43","doi-asserted-by":"publisher","unstructured":"The Gene Ontology Consortium (2019) The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res 47:D330\u2013D338. https:\/\/doi.org\/10.1093\/nar\/gky1055","DOI":"10.1093\/nar\/gky1055"},{"key":"1923_CR44","doi-asserted-by":"publisher","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","volume":"44","author":"A Fabregat","year":"2016","unstructured":"Fabregat A, Sidiropoulos K, Garapati P, Gillespie M, Hausmann K, Haw R, Jassal B, Jupe S, Korninger F, McKay S, Matthews L, May B, Milacic M, Rothfels K, Shamovsky V, Webber M, Weiser J, Williams M, Wu G, Stein L, Hermjakob H, D\u2019Eustachio P (2016) The reactome pathway knowledgebase. Nucleic Acids Res 44:D481\u2013D487. https:\/\/doi.org\/10.1093\/nar\/gkv1351","journal-title":"Nucleic Acids Res"},{"key":"1923_CR45","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gky1051","volume":"47","author":"L Cheng","year":"2019","unstructured":"Cheng L, Wang P, Tian R, Wang S, Guo Q, Luo M, Zhou W, Liu G, Jiang H, Jiang Q (2019) LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse. Nucleic Acids Res 47:D140\u2013D144. https:\/\/doi.org\/10.1093\/nar\/gky1051","journal-title":"Nucleic Acids Res"},{"key":"1923_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jgg.2017.01.004","volume":"44","author":"C-J Liu","year":"2017","unstructured":"Liu C-J, Gao C, Ma Z, Cong R, Zhang Q, Guo A-Y (2017) lncRInter: a database of experimentally validated long non-coding RNA interaction. J Genet Genomics 44:265\u2013268","journal-title":"J Genet Genomics"},{"key":"1923_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1049\/iet-syb.2016.0001","volume":"10","author":"E Gov","year":"2016","unstructured":"Gov E, Arga KY (2016) Interactive cooperation and hierarchical operation of microRNA and transcription factor crosstalk in human transcriptional regulatory network. IET Syst Biol 10:219\u2013228. https:\/\/doi.org\/10.1049\/iet-syb.2016.0001","journal-title":"IET Syst Biol"},{"key":"1923_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jtbi.2016.05.020","volume":"403","author":"K Karagoz","year":"2016","unstructured":"Karagoz K, Sevimoglu T, Arga KY (2016) Integration of multiple biological features yields high confidence human protein interactome. J Theor Biol 403:85\u201396","journal-title":"J Theor Biol"},{"key":"1923_CR49","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"1923_CR50","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11","journal-title":"BMC Syst Biol"},{"key":"1923_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1158140","author":"M Campillos","year":"2008","unstructured":"Campillos M, Kuhn M, Gavin A-C, Jensen LJ, Bork P (2008) Drug target identification using side-effect similarity. Science. https:\/\/doi.org\/10.1126\/science.1158140","journal-title":"Science"},{"key":"1923_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjsba.2016.15","volume":"2","author":"Q Duan","year":"2016","unstructured":"Duan Q, Reid SP, Clark NR, Wang Z, Fernandez NF, Rouillard AD, Readhead B, Tritsch SR, Hodos R, Hafner M (2016) L1000CDS 2: LINCS L1000 characteristic direction signatures search engine. NPJ Syst Biol Appl 2:1\u201312","journal-title":"NPJ Syst Biol Appl"},{"key":"1923_CR53","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2019) PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47:D1102\u2013D1109. https:\/\/doi.org\/10.1093\/nar\/gky1033","journal-title":"Nucleic Acids Res"},{"key":"1923_CR54","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2017.0127","author":"B Turanli","year":"2017","unstructured":"Turanli B, Gulfidan G, Arga KY (2017) Transcriptomic-Guided drug repositioning supported by a new bioinformatics search tool: Genexpharma. Omi A J Integr Biol. https:\/\/doi.org\/10.1089\/omi.2017.0127","journal-title":"Omi A J Integr Biol"},{"key":"1923_CR55","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ (2021) Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res 49:D1138\u2013D1143. https:\/\/doi.org\/10.1093\/nar\/gkaa891","journal-title":"Nucleic Acids Res"},{"key":"1923_CR56","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nsb1203-980","volume":"10","author":"H Berman","year":"2003","unstructured":"Berman H, Henrick K, Nakamura H (2003) Announcing the worldwide protein data bank. Nat Struct Mol Biol 10:980","journal-title":"Nat Struct Mol Biol"},{"key":"1923_CR57","doi-asserted-by":"publisher","unstructured":"UniProt Consortium (2021) UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49(D1):D480\u2013D489. https:\/\/doi.org\/10.1093\/nar\/gkaa1100","DOI":"10.1093\/nar\/gkaa1100"},{"key":"1923_CR58","doi-asserted-by":"publisher","first-page":"D308","DOI":"10.1093\/nar\/gkp916","volume":"38","author":"S Velankar","year":"2010","unstructured":"Velankar S, Best C, Beuth B, Boutselakis CH, Cobley N, Sousa Da Silva AW, Dimitropoulos D, Golovin A, Hirshberg M, John M (2010) PDBe: protein data bank in Europe. Nucleic Acids Res 38:D308\u2013D317","journal-title":"Nucleic Acids Res"},{"key":"1923_CR59","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkq406","volume":"38","author":"MN Wass","year":"2010","unstructured":"Wass MN, Kelley LA, Sternberg MJE (2010) 3DLigandSite: predicting ligand-binding sites using similar structures. Nucleic Acids Res 38:W469\u2013W473","journal-title":"Nucleic Acids Res"},{"key":"1923_CR60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"1923_CR61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"A-L Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si A-L, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56\u201368. https:\/\/doi.org\/10.1038\/nrg2918","journal-title":"Nat Rev Genet"},{"key":"1923_CR62","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli M-T, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96:1297\u20131325","journal-title":"Physiol Rev"},{"key":"1923_CR63","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fendo.2020.00471","volume":"11","author":"M Mormando","year":"2020","unstructured":"Mormando M, Puliani G, Barnabei A, Lauretta R, Bianchini M, Chiefari A, Russillo M, Cognetti F, Romano L, Appetecchia M (2020) A rare case of pituitary melanoma metastasis: a dramatic and prolonged response to dabrafenib-trametinib therapy. Front Endocrinol (Lausanne) 11:471","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1923_CR64","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2018.2.FOCUS17660","volume":"44","author":"E Anderson","year":"2018","unstructured":"Anderson E, Heller RS, Lechan RM, Heilman CB (2018) Regression of a nonfunctioning pituitary macroadenoma on the CDK4\/6 inhibitor palbociclib: case report. Neurosurg Focus 44:E9. https:\/\/doi.org\/10.3171\/2018.2.FOCUS17660","journal-title":"Neurosurg Focus"},{"key":"1923_CR65","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3892\/ijmm.2020.4807","volume":"47","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li Z, Fang Q, Wang H, Li C, Gao H, Zhang Y (2020) CDKN2A (p16INK4A) affects the anti-tumor effect of CDK inhibitor in somatotroph adenomas. Int J Mol Med 47:500\u2013510. https:\/\/doi.org\/10.3892\/ijmm.2020.4807","journal-title":"Int J Mol Med"},{"key":"1923_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01758-x","author":"C Campana","year":"2022","unstructured":"Campana C, Nista F, Castelletti L, Caputo M, Lavezzi E, Marzullo P, Gatto F (2022) Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature. J Endocrinol Investig. https:\/\/doi.org\/10.1007\/s40618-022-01758-x","journal-title":"J Endocrinol Investig"},{"key":"1923_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ (2016) Roles, functions, and mechanisms of long non-coding RNAS in cancer. Genom Proteom Bioinformat 14:42\u201354. https:\/\/doi.org\/10.1016\/j.gpb.2015.09.006","journal-title":"Genom Proteom Bioinformat"},{"key":"1923_CR68","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1042\/BCJ20170079","volume":"474","author":"O Slaby","year":"2017","unstructured":"Slaby O, Laga R, Sedlacek O (2017) Therapeutic targeting of non-coding RNAs in cancer. Biochem J 474:4219\u20134251. https:\/\/doi.org\/10.1042\/BCJ20170079","journal-title":"Biochem J"},{"key":"1923_CR69","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1210\/jc.2018-01851","volume":"104","author":"Q Du","year":"2019","unstructured":"Du Q, Hu B, Feng Y, Wang Z, Wang X, Zhu D, Zhu Y, Jiang X, Wang H (2019) circOMA1-Mediated miR-145-5p suppresses tumor growth of nonfunctioning pituitary adenomas by targeting TPT1. J Clin Endocrinol Metab 104:2419\u20132434. https:\/\/doi.org\/10.1210\/jc.2018-01851","journal-title":"J Clin Endocrinol Metab"},{"key":"1923_CR70","first-page":"2995","volume":"21","author":"M Cui","year":"2017","unstructured":"Cui M, Zhang M, Liu H-F, Wang J-P (2017) Effects of microRNA-21 targeting PITX2 on proliferation and apoptosis of pituitary tumor cells. Eur Rev Med Pharmacol Sci 21:2995\u20133004","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1923_CR71","doi-asserted-by":"publisher","first-page":"E708","DOI":"10.1152\/ajpendo.00546.2011","volume":"303","author":"G Trivellin","year":"2012","unstructured":"Trivellin G, Butz H, Delhove J, Igreja S, Chahal HS, Zivkovic V, McKay T, Pat\u00f3cs A, Grossman AB, Korbonits M (2012) MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab 303:E708\u2013E719. https:\/\/doi.org\/10.1152\/ajpendo.00546.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1923_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/life10050059","volume":"10","author":"J Boresowicz","year":"2020","unstructured":"Boresowicz J, Kober P, Rusetska N, Maksymowicz M, Paziewska A, D\u0105browska M, Zeber-Lubecka N, Kunicki J, Bonicki W, Ostrowski J (2020) DNA Methylation Influences miRNA expression in gonadotroph pituitary tumors. Life 10:59","journal-title":"Life"},{"key":"1923_CR73","doi-asserted-by":"crossref","unstructured":"Haddick PCG, Tom I, Luis E, Qui\u00f1ones G, Wranik BJ, Ramani SR, Stephan J-P, Tessier-Lavigne M, Gonzalez LC (2014) Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptor. PLoS One 9:e84823","DOI":"10.1371\/journal.pone.0084823"},{"key":"1923_CR74","doi-asserted-by":"crossref","unstructured":"Nakamura H, Sudo T, Tsuiki H, Miyake H, Morisaki T, Sasaki J, Masuko N, Kochi M, Ushio Y, Saya H (1998) Identification of a novel human homolog of the Drosophila dlg, P\u2010dlg, specifically expressed in the gland tissues and interacting with p55. FEBS Lett 433:63\u201367","DOI":"10.1016\/S0014-5793(98)00882-5"},{"key":"1923_CR75","doi-asserted-by":"crossref","unstructured":"Dwyer J, Li HE, Xu D, LIU J (2007) Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann N Y Acad Sci 1114:36\u201347","DOI":"10.1196\/annals.1396.022"},{"key":"1923_CR76","doi-asserted-by":"crossref","unstructured":"Nakae J, Kitamura T, Kitamura Y, Biggs III WH, Arden KC, Accili D (2003) The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 4:119\u2013129","DOI":"10.1016\/S1534-5807(02)00401-X"},{"key":"1923_CR77","doi-asserted-by":"crossref","unstructured":"Sampson EM, Haque ZK, Ku M, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS (2001) Negative regulation of the Wnt\u2013\u03b2\u2010catenin pathway by the transcriptional repressor HBP1. EMBO J 20:4500\u20134511","DOI":"10.1093\/emboj\/20.16.4500"},{"key":"1923_CR78","doi-asserted-by":"publisher","unstructured":"Taherbhoy AM, Huang OW, Cochran AG (2015) BMI1-RING1B is an autoinhibited RING E3 ubiquitin ligase. Nat Commun 6:7621. https:\/\/doi.org\/10.1038\/ncomms8621","DOI":"10.1038\/ncomms8621"},{"key":"1923_CR79","doi-asserted-by":"publisher","unstructured":"Taherbhoy AM, Huang OW, Cochran AG (2015) BMI1-RING1B is an autoinhibited RING E3 ubiquitin ligase. Nat Commun 6:7621. https:\/\/doi.org\/10.1038\/ncomms8621","DOI":"10.1038\/ncomms8621"},{"key":"1923_CR80","doi-asserted-by":"publisher","unstructured":"Qian M-X, Pang Y, Liu CH, Haratake K, Du B-Y, Ji D-Y, Wang G-F, Zhu Q-Q, Song W, Yu Y, Zhang X-X, Huang H-T, Miao S, Chen L-B, Zhang Z-H, Liang Y-N, Liu S, Cha H, Yang D, Zhai Y, Komatsu T, Tsuruta F, Li H, Cao C, Li W, Li G-H, Cheng Y, Chiba T, Wang L, Goldberg AL, Shen Y, Qiu X-B (2013) Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell 153:1012\u20131024. https:\/\/doi.org\/10.1016\/j.cell.2013.04.032","DOI":"10.1016\/j.cell.2013.04.032"},{"key":"1923_CR81","doi-asserted-by":"publisher","unstructured":"Sun Y, Ding L, Zhang H, Han J, Yang X, Yan J, Zhu Y, Li J, Song H, Ye Q (2006) Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS. Nucleic Acids Res 34:6314\u20136326 . https:\/\/doi.org\/10.1093\/nar\/gkl914","DOI":"10.1093\/nar\/gkl914"},{"key":"1923_CR82","doi-asserted-by":"crossref","unstructured":"Date S, Nibu Y, Yanai K, Hirata J, Yagami K-I, Fukamizu A (2004) Finb, a multiple zinc finger protein, represses transcription of the human angiotensinogen gene. Int J Mol Med 13:637\u2013642","DOI":"10.3892\/ijmm.13.5.637"},{"key":"1923_CR83","doi-asserted-by":"crossref","unstructured":"Lin W, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. Am Soc Clin Investig 117:1175\u20131183","DOI":"10.1172\/JCI31537"},{"key":"1923_CR84","doi-asserted-by":"publisher","unstructured":"Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Ki N, Yoshimura A (2001) The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 276:12530\u201312538 . https:\/\/doi.org\/10.1074\/jbc.M010074200","DOI":"10.1074\/jbc.M010074200"},{"key":"1923_CR85","doi-asserted-by":"publisher","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872 . https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","DOI":"10.1016\/j.cell.2007.11.019"},{"key":"1923_CR86","doi-asserted-by":"publisher","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai Z-C, Guan K-L (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21:2747\u20132761. https:\/\/doi.org\/10.1101\/gad.1602907","DOI":"10.1101\/gad.1602907"},{"key":"1923_CR87","doi-asserted-by":"publisher","unstructured":"Mabuchi M, Kataoka H, Miura Y, Kim T-S, Kawaguchi M, Ebi M, Tanaka M, Mori Y, Kubota E, Mizushima T, Shimura T, Mizoshita T, Tanida S, Kamiya T, Asai K, Joh T (2010) Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction. Biochem Biophys Res Commun 398:321\u2013325. https:\/\/doi.org\/10.1016\/j.bbrc.2010.06.090","DOI":"10.1016\/j.bbrc.2010.06.090"},{"key":"1923_CR88","doi-asserted-by":"crossref","unstructured":"Lv T, Zhang Z, Yu H, Ren S, Wang J, Li S et al (2022) Tamoxifen exerts anticancer effects on pituitary adenoma progression via inducing cell apoptosis and inhibiting cell migration. Int J Mol Sci 23:2664","DOI":"10.3390\/ijms23052664"},{"key":"1923_CR89","doi-asserted-by":"crossref","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V et al (2018) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178:G1\u201324","DOI":"10.1530\/EJE-17-0796"},{"key":"1923_CR90","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1530\/ERC-20-0136","volume":"27","author":"MP Yavropoulou","year":"2020","unstructured":"Yavropoulou MP, Tsoli M, Barkas K, Kaltsas G, Grossman A (2020) The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs). Endocr Relat Cancer 27:R375\u2013R390","journal-title":"Endocr Relat Cancer"},{"key":"1923_CR91","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1021\/jm049354h","volume":"48","author":"PL Toogood","year":"2005","unstructured":"Toogood PL, Harvey PJ, Repine JT, Sheehan DJ, VanderWel SN, Zhou H, Keller PR, McNamara DJ, Sherry D, Zhu T, Brodfuehrer J, Choi C, Barvian MR, Fry DW (2005) Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4\/6. J Med Chem 48:2388\u20132406. https:\/\/doi.org\/10.1021\/jm049354h","journal-title":"J Med Chem"},{"key":"1923_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1505270","volume":"373","author":"NC Turner","year":"2015","unstructured":"Turner NC, Ro J, Andr\u00e9 F, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, Huang Bartlett C, Zhang K, Giorgetti C, Randolph S, Koehler M, Cristofanilli M (2015) Palbociclib in hormone-receptor\u2013positive advanced breast cancer. N Engl J Med 373:209\u2013219. https:\/\/doi.org\/10.1056\/NEJMoa1505270 (Epub 2015 Jun 1. PMID: 26030518)","journal-title":"N Engl J Med"},{"key":"1923_CR93","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1002\/ijc.23380","volume":"122","author":"A Italiano","year":"2008","unstructured":"Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre J, Dumollard J, Hofman P, Leroux A, Mainguen\u00e9 C (2008) HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J cancer 122:2233\u20132241","journal-title":"Int J cancer"},{"key":"1923_CR94","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccr.2006.04.024","volume":"9","author":"M Fedele","year":"2006","unstructured":"Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM (2006) HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9:459\u2013471","journal-title":"Cancer Cell"},{"key":"1923_CR95","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1586\/14737140.2015.1042369","volume":"15","author":"C Aversa","year":"2015","unstructured":"Aversa C, Leone F, Zucchini G, Serini G, Geuna E, Milani A, Valdembri D, Martinello R, Montemurro F (2015) Linifanib: current status and future potential in cancer therapy. Expert Rev Anticancer Ther 15:677\u2013687","journal-title":"Expert Rev Anticancer Ther"},{"key":"1923_CR96","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/JTO.0b013e318220c93e","volume":"6","author":"E-H Tan","year":"2011","unstructured":"Tan E-H, Goss GD, Salgia R, Besse B, Gandara DR, Hanna NH, Yang JC-H, Thertulien R, Wertheim M, Mazieres J (2011) Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer. J Thorac Oncol 6:1418\u20131425","journal-title":"J Thorac Oncol"},{"key":"1923_CR97","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1200\/JCO.2013.54.3298","volume":"33","author":"C Cainap","year":"2015","unstructured":"Cainap C, Qin S, Huang W-T, Chung IJ, Pan H, Cheng Y, Kudo M, Kang Y-K, Chen P-J, Toh H-C (2015) Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. J Clin Oncol 33:172","journal-title":"J Clin Oncol"},{"key":"1923_CR98","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3109\/10428194.2012.660631","volume":"53","author":"ES Wang","year":"2012","unstructured":"Wang ES, Yee K, Koh LP, Hogge D, Enschede S, Carlson DM, Dudley M, Glaser K, McKeegan E, Albert DH (2012) Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia. Leuk Lymphoma 53:1543\u20131551","journal-title":"Leuk Lymphoma"},{"key":"1923_CR99","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1535-7163.MCT-05-0410","volume":"5","author":"DH Albert","year":"2006","unstructured":"Albert DH, Tapang P, Magoc TJ, Pease LJ, Reuter DR, Wei R-Q, Li J, Guo J, Bousquet PF, Ghoreishi-Haack NS (2006) Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor. Mol Cancer Ther 5:995\u20131006","journal-title":"Mol Cancer Ther"},{"key":"1923_CR100","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11102-011-0346-8","volume":"15","author":"LD Ortiz","year":"2012","unstructured":"Ortiz LD, Syro LV, Scheithauer BW, Ersen A, Uribe H, Fadul CE, Rotondo F, Horvath E, Kovacs K (2012) Anti-VEGF therapy in pituitary carcinoma. Pituitary 15:445\u2013449","journal-title":"Pituitary"},{"key":"1923_CR101","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s40265-013-0096-1","volume":"73","author":"CJM Wright","year":"2013","unstructured":"Wright CJM, McCormack PL (2013) Trametinib: first global approval. Drugs 73:1245\u20131254","journal-title":"Drugs"},{"key":"1923_CR102","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L (2015) Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 372:30\u201339","journal-title":"N Engl J Med"},{"issue":"2","key":"1923_CR103","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1593\/neo.121712","volume":"15","author":"DM Walters","year":"2013","unstructured":"Walters DM, Lindberg JM, Adair SJ, Newhook TE, Cowan CR, Stokes JB, Borgman CA, Stelow EB, Lowrey BT, Chopivsky ME (2013) Inhibition of the growth of patient derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor HER2 inhibitor lapatinib. Neoplasia 15(2):143-IN10","journal-title":"Neoplasia"},{"key":"1923_CR104","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S1470-2045(16)30146-2","volume":"17","author":"D Planchard","year":"2016","unstructured":"Planchard D, Besse B, Groen HJM, Souquet P-J, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S (2016) Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. Lancet Oncol 17:984\u2013993","journal-title":"Lancet Oncol"},{"key":"1923_CR105","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1200\/JCO.2015.63.2471","volume":"33","author":"RB Corcoran","year":"2015","unstructured":"Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R (2015) Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600\u2013mutant colorectal cancer. J Clin Oncol 33:4023","journal-title":"J Clin Oncol"},{"key":"1923_CR106","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.677.677","author":"G Borthakur","year":"2012","unstructured":"Borthakur G, Popplewell L, Boyiadzis M, Foran JM, Platzbecker U, Vey N, Roland WB, Olin RL, Raza A, Giagounidis A (2012) Phase I\/II trial of the MEK1\/2 inhibitor trametinib (GSK1120212) in relapsed\/refractory myeloid malignancies: evidence of activity in patients with RAS mutation-positive disease. Blood. https:\/\/doi.org\/10.1182\/blood.V120.21.677.677","journal-title":"Blood"},{"key":"1923_CR107","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.21873\/anticanres.13549","volume":"39","author":"L Sollfrank","year":"2019","unstructured":"Sollfrank L, Lettmaier S, Erdmann M, Uslu U (2019) Panniculitis under successful targeted inhibition of the MAPK\/ERK signaling pathway in a patient with BRAF V600E-mutated spindle cell oncocytoma of the pituitary gland. Anticancer Res 39:3955\u20133959","journal-title":"Anticancer Res"},{"key":"1923_CR108","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv310","author":"PK Brastianos","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS (2016) Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. JNCI J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv310","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1923_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0922-4106(89)90004-7","volume":"172","author":"R Boer","year":"1989","unstructured":"Boer R, Grassegger A, Schudt C, Glossmann H (1989) (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of \u03b11-adrenoceptors. Eur J Pharmacol Mol Pharmacol 172:131\u2013145","journal-title":"Eur J Pharmacol Mol Pharmacol"},{"key":"1923_CR110","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1476-5381.1989.tb12037.x","volume":"97","author":"U Kl\u00f6ckner","year":"1989","unstructured":"Kl\u00f6ckner U, Isenberg G (1989) The dihydropyridine niguldipine modulates calcium and potassium currents in vascular smooth muscle cells. Br J Pharmacol 97:957","journal-title":"Br J Pharmacol"},{"key":"1923_CR111","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.3390\/ijms20246112","volume":"20","author":"AR Lee","year":"2019","unstructured":"Lee AR, Seo MJ, Kim J, Lee DM, Kim IY, Yoon MJ, Hoon H, Choi KS (2019) Lercanidipine synergistically enhances bortezomib cytotoxicity in cancer cells via enhanced endoplasmic reticulum stress and mitochondrial Ca2+ Overload. Int J Mol Sci 20:6112","journal-title":"Int J Mol Sci"},{"key":"1923_CR112","unstructured":"Wee S (2015) Identification of compounds that target glioma initiating cells. Inst f\u00f6r fysiologi och farmakologi\/Dept of Physiology and Pharmacology"},{"key":"1923_CR113","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/jm960697s","volume":"40","author":"B Kenny","year":"1997","unstructured":"Kenny B, Ballard S, Blagg J, Fox D (1997) Pharmacological options in the treatment of benign prostatic hyperplasia. J Med Chem 40:1293\u20131315","journal-title":"J Med Chem"},{"key":"1923_CR114","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.2174\/092986706779010315","volume":"13","author":"K Kulig","year":"2006","unstructured":"Kulig K, Malawska B (2006) Trends in the development of new drugs for treatment of benign prostatic hyperplasia. Curr Med Chem 13:3395\u20133416","journal-title":"Curr Med Chem"},{"key":"1923_CR115","volume-title":"Cochrane Database Syst Rev","author":"RC Gibson","year":"2004","unstructured":"Gibson RC, Fenton M, da Coutinho E, SF, Campbell C, (2004) Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database Syst Rev. John Wiley, Chichester"},{"key":"1923_CR116","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1191\/0960327104ht470oa","volume":"23","author":"AE Khalifa","year":"2004","unstructured":"Khalifa AE (2004) Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats. Hum Exp Toxicol 23:439\u2013445","journal-title":"Hum Exp Toxicol"},{"key":"1923_CR117","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00406-013-0413-4","volume":"264","author":"G Fond","year":"2014","unstructured":"Fond G, Macgregor A, Tamouza R, Hamdani N, Meary A, Leboyer M, Dubremetz J-F (2014) Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci 264:179\u2013183","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1923_CR118","unstructured":"Bourdoulous S, Faure C (2020) Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors.Google Patents. https:\/\/patents.google.com\/patent\/WO2017121755A1\/en."},{"key":"1923_CR119","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1527-3466.2003.tb00114.x","volume":"21","author":"CT Stier","year":"2003","unstructured":"Stier CT (2003) Eplerenone: a selective aldosterone blocker. Cardiovasc Drug Rev 21:169\u2013184. https:\/\/doi.org\/10.1111\/j.1527-3466.2003.tb00114.x","journal-title":"Cardiovasc Drug Rev"},{"key":"1923_CR120","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH, Roniker B, Krause SL, Weiss RJ (2002) Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 15:709\u2013716","journal-title":"Am J Hypertens"},{"key":"1923_CR121","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"key":"1923_CR122","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11\u201321","journal-title":"N Engl J Med"},{"key":"1923_CR123","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, C\u00e9l\u00e9rier I, Bousquet E, Jeanny J-C, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Investig 122:2672\u20132679","journal-title":"J Clin Investig"},{"key":"1923_CR124","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2215\/CJN.00240106","volume":"1","author":"M Epstein","year":"2006","unstructured":"Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B (2006) Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol 1:940\u2013951","journal-title":"Clin J Am Soc Nephrol"},{"key":"1923_CR125","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ki.2011.505","volume":"81","author":"L Shavit","year":"2012","unstructured":"Shavit L, Lifschitz MD, Epstein M (2012) Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms. Kidney Int 81:955\u2013968","journal-title":"Kidney Int"},{"key":"1923_CR126","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000515801","volume":"112","author":"B Aydin","year":"2022","unstructured":"Aydin B, Arslan S, Bayrakl\u0131 F, Karademir B, Arga KY (2022) MicroRNA-Mediated drug repurposing unveiled potential candidate drugs for prolactinoma treatment. Neuroendocrinology 112:161\u2013173","journal-title":"Neuroendocrinology"},{"key":"1923_CR127","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13167-021-00246-1","volume":"12","author":"B Aydin","year":"2021","unstructured":"Aydin B, Caliskan A, Arga KY (2021) Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies. EPMA J 12:383\u2013401","journal-title":"EPMA J"},{"key":"1923_CR128","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/omi.2021.0221","volume":"26","author":"B Aydin","year":"2022","unstructured":"Aydin B, Yildirim E, Erdogan O, Arga KY, Yilmaz BK, Bozkurt SU et al (2022) Past, present, and future of therapies for pituitary neuroendocrine tumors: need for omics and drug repositioning guidance. Omi A J Integr Biol 26:115\u2013129","journal-title":"Omi A J Integr Biol"},{"key":"1923_CR129","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A, Assi\u00e9 G (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37:123\u2013134","journal-title":"Cancer Cell"},{"issue":"3","key":"1923_CR130","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12022-021-09671-4","volume":"32","author":"O Mete","year":"2021","unstructured":"Mete O, Ezzat S, Perry A, Yamada S, Uccella S, Grossman AB, Asa SL (2021) The pangenomic classification of pituitary neuroendocrine tumors: quality histopathology is required for accurate translational research. Endocr Pathol 32(3):415\u2013417","journal-title":"Endocr Pathol"},{"key":"1923_CR131","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40618-020-01379-2","volume":"44","author":"C Di Somma","year":"2021","unstructured":"Di Somma C, Scarano E, de Alteriis G, Barrea L, Riccio E, Arianna R, Colao A (2021) Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a national referral center and review of the literature. J Endocrinol Investig 44:957\u2013968","journal-title":"J Endocrinol Investig"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01923-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:49:21Z","timestamp":1701283761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01923-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":131,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01923-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that the datasets used in this study belonged to previously published studies, therefore no ethical statement is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}